首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1498610

動物保健市場規模、佔有率、成長分析、按動物類型、按產品、按分銷管道、按最終用途、按地區 - 行業預測，2024-2031 年

Animal Health Market Size, Share, Growth Analysis, By Animal Type(Production Animals ), By Product(Biologics ), By Distribution Channel, By End Use, By Region - Industry Forecast 2024-2031

出版日期: 2024年06月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年動物保健市場規模將為582.8億美元，預測期內（2024-2031年）複合年成長率為8.1%，從2023年的630億美元增至2031年的1174.8億美元，預計還會成長。

動物保健市場包括各種動物保健產品的製造商和生產商，例如疫苗、診斷劑、抗生素、數位技術和其他設備。全球畜牧業生產不斷成長，畜牧業提供了食物、安全和陪伴。監測動物健康至關重要，因為過去 30 年來 75% 的新人類疾病都是動物感染疾病。充滿活力和創新的動物保健產業致力於伴同性動物（寵物）和食用動物的疫苗和其他產品的研究、開發、授權和分銷，提供高品質、安全和有效的解決方案。此外，動物還可以作為遺傳學和藥物測試等生物學研究領域的模型。人們對動物疾病的認知不斷提高，嚴格的法規以及對動物傳染病預防的更加重視正在推動各領域動物保健品市場的快速擴張。

藥品
- 寄生劑
- 抗感染
- 發炎
- 止痛藥
- 其他
藥物飼料添加劑
診斷
- 耗材、試劑、套件
- 設備/設備
設備/消耗品
- 重症加護耗材
- 麻醉設備
- 流體管理裝置
- 溫控設備
- 救援和復甦設備
- 調查設備
- 病患監測裝置
其他
- 獸醫遠端醫療
- 獸醫軟體
- 牲畜監測

動物保健市場：依動物分類

市場概況
生產動物
- 家禽
- 豬
- 牛
- 綿羊山羊
- 魚
伴同性動物
- 狗
- 貓
- 馬
- 其他

動物保健市場：依分銷管道分類

市場概況
零售
電子商務
醫院/診所藥房

動物保健市場：依最終用戶分類

市場概況
動物醫院/診所
動物照護與復健中心
診斷中心
其他

動物保健市場規模：按地區分類

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Zoetis Inc.（United States）
Merck Animal Health（United States）
Elanco Animal Health（United States）
Boehringer Ingelheim Animal Health（Germany）
Bayer Animal Health（Germany）
Virbac（France）
Ceva Sante Animale（France）
IDEXX Laboratories, Inc.（United States）
Vetoquinol SA（France）
Dechra Pharmaceuticals PLC（United Kingdom）
Neogen Corporation（United States）
Phibro Animal Health Corporation（United States）
Kindred Biosciences, Inc.（United States）
Norbrook Holdings Limited（United Kingdom）
Heska Corporation（United States）
Nutreco NV（Netherlands）
AniCura AB（Sweden）
PetIQ, Inc.（United States）
Petmed Express, Inc.（United States）

簡介目錄

Product Code: SQMIG35D2005

Animal Health Market size was valued at USD 58.28 billion in 2022 and is poised to grow from USD 63 billion in 2023 to USD 117.48 billion by 2031, at a CAGR of 8.1% over the forecast period (2024- 2031).

The animal health market encompasses manufacturers and producers of various animal health products, including vaccines, diagnostics, antibiotics, digital technology, and other equipment. Global livestock production has been on the rise, as animals provide food, security, and companionship. Monitoring animal health is crucial, given that experts estimate at least 60% of all human diseases can be transmitted between humans and animals, with 75% of emerging human diseases in the past three decades originating from animals or being zoonotic. The dynamic and innovative animal health industry is dedicated to researching, developing, licensing, and distributing vaccines and other products for both companion animals (pets) and food animals, ensuring high-quality, safe, and effective solutions. Additionally, animals serve as models in biological research areas such as genetics and drug testing. The increasing awareness of animal diseases, stringent regulations, and a greater emphasis on preventing diseases from animal epidemics are driving the rapid expansion of the animal health products market across various sectors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Animal Health Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Animal Health Market Segmental Analysis

The global animal health market is categorized by product, animal type, end-user, and region. The product segments include vaccines, pharmaceuticals, diagnostics, and feed additives. The animal segments are divided into livestock animals and companion animals. The end-user segments encompass veterinary hospitals and clinics, animal care and rehabilitation centers, diagnostic centers, and others. Geographically, the market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA).

Drivers of the Animal Health Market

The animal health market is expected to be driven by the rise of zoonotic diseases, which are among the most contagious globally. The growing trend of pet adoption as companions contributes to the spread of these animal-borne diseases, highlighting the need for increased awareness of prevention strategies. Additionally, the expansion of therapeutic options is anticipated to boost the demand for veterinary care products. Zoonotic diseases, capable of transmission between animals and humans, present significant public health challenges, emphasizing the necessity for proactive measures to mitigate their spread.

Restraints in the Animal Health Market

Stringent government regulations concerning drug approvals may hinder market growth. In the United States, all veterinary drugs must receive approval from the Food and Drug Administration (FDA). According to the Animal Health Organization, developing a new veterinary drug can take up to a decade and cost over $100 million, while creating a new vaccine can take three to five years and cost around $80 million before gaining approval. Additionally, manufacturers of animal health products are required to pay user fees under the Animal Drug Use Act (ADUF) and the Veterinary Drug Use Fee Act. These regulatory requirements are expected to impede the growth of the global animal health market during the forecast period.

Market Trends of the Animal Health Market

Technological advances are revolutionizing the animal health industry, spurring significant growth and innovation. Sophisticated tools like gene editing, precision medicine, and digital health monitoring are transforming the sector. Our analysis predicts that the animal health market will reach $12.6 billion by 2025, growing at a rate of 8.8%. Innovations such as wearable devices for tracking vital signs and AI-powered diagnostic tools are enhancing disease prevention, recovery, and treatment, ultimately improving animal welfare and productivity at both farm and household levels.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
PESTEL Analysis
Pricing Analysis
Pet Owner Demographics in key Countries

Global Animal Health Market by Product

Market Overview
Biologics
- Vaccines

Modified/ Attenuated Live

Inactivated (Killed)

Other Vaccines

Other Biologics

Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
Medicinal Feed Additives
Diagnostics
- Consumables, Reagent, and Kits
- Instruments and Devices
Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring

Global Animal Health Market by Animals

Market Overview
Production Animals
- Poultry
- Swine
- Cattle
- Sheep & Goats
- Fish
Companion Animals
- Dogs
- Cats
- Horses
- Others

Global Animal Health Market by Distribution Channel

Market Overview
Retail
E-commerce
Hospital/ Clinic Pharmacy

Global Animal Health Market by End User

Market Overview
Veterinary Hospitals & Clinics
Animal Care & Rehabilitation Centers
Diagnostic Centers
Others

Global Animal Health Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Zoetis Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Animal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim Animal Health (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer Animal Health (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Sante Animale (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEXX Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dechra Pharmaceuticals PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phibro Animal Health Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kindred Biosciences, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norbrook Holdings Limited (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heska Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nutreco N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AniCura AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PetIQ, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Update
- Key Developments
Petmed Express, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments